IUX24IUX24
TopMarketWorldEconomyFinanceTechnologyBusinessPolitics

UK Approves Novo Nordisk Weight Loss Pill

The UK medicines regulator has approved an oral version of Novo Nordisk semaglutide treatment for obesity. This decision provides an alternative to injections for millions of patients and marks the first European clearance for the pill as competition with Eli Lilly intensifies in the global market.

X24 AIX24 Perspective
Related Assets:

Related News
IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

Grand Pavilion, Hibiscus Way, 802 West Bay Road, Grand Cayman, KY1 - 1205 , Cayman Islands

Copyright IUX24 Media LTD. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and intelligence platform. This site provides market news and analytical data only; it does not constitute investment advice, individual trading signals, or brokerage services. All information is for educational and informational purposes. Trading involves significant risk, and we recommend consulting with a qualified financial professional before making any investment decisions.